4.7 Article

An optimized SpCas9 high-fidelity variant for direct protein delivery

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Automated identification of sequence-tailored Cas9 proteins using massive metagenomic data

Matteo Ciciani et al.

Summary: By developing a computational pipeline, researchers can accurately predict and isolate Cas9 nucleases targeting specific sequences, including using mutated sequences as PAM. This approach will be instrumental in generating a repertoire of Cas9 nucleases responding to any PAM requirement.

NATURE COMMUNICATIONS (2022)

Review Biotechnology & Applied Microbiology

Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing

Rongming Liu et al.

Summary: CRISPR technology, a universal tool for genome engineering, has been revolutionizing biotechnology. The diverse Cas proteins with complex structures contain multiple evolutionarily conserved functional domains, and engineering key domains can modify the functions of CRISPR/Cas systems.

TRENDS IN BIOTECHNOLOGY (2021)

Article Medicine, General & Internal

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

H. Frangoul et al.

Summary: Research utilizing CRISPR-Cas9 technology for gene editing in patients with TDT and SCD showed high levels of edited alleles in bone marrow and blood, leading to partial or complete elimination of symptoms.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Medicine, General & Internal

Genome Editing for β-Hemoglobinopathies: Advances and Challenges

Giacomo Frati et al.

Summary: Beta-hemoglobinopathies are genetic disorders caused by mutations affecting adult hemoglobin production or structure, leading to anemia and multi-organ damage. Current therapeutic options include symptomatic care, blood transfusions, and pharmacological treatments, with lentiviral-mediated gene therapy showing promise but being costly and variable in outcomes. Genome editing has emerged as a valuable tool for developing curative strategies for beta-hemoglobinopathies, with a focus on correcting defective beta-globin genes or inducing fetal hemoglobin production.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Hematology

Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells

Giulia Pavani et al.

Summary: Beta-thalassemias are blood disorders caused by mutations in the beta-globin gene cluster. A novel strategy using CRISPR/Cas9 to edit the alpha-globin locus in human HSPCs has been developed to correct alpha/beta globin imbalance in thalassemic cells, showing potential for new therapeutic approaches. This approach combines alpha-globin downregulation with beta-globin expression to address the underlying pathology of beta-thalassemias.

BLOOD ADVANCES (2021)

Article Cell Biology

Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease

Annalisa Lattanzi et al.

Summary: This study demonstrated the preclinical feasibility, efficacy, and toxicology of HBB gene correction in CD34(+) cells from healthy and SCD patient donors. Up to 60% HBB allelic correction was achieved in clinical-scale gcHBB-SCD manufacturing, with 20% gene correction in immunodeficient NSG mice after transplant.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Biochemical Research Methods

CRISPR/Cas9 ribonucleoprotein-mediated knockin generation in hTERT-RPE1 cells

Sabrina Ghetti et al.

Summary: This article describes a rapid and efficient method for generating diverse homozygous knockins, which can be applied to various cell types, including cancer cells and induced pluripotent stem cells (iPSCs). The approach bypasses the need for molecular cloning, making it a versatile tool for gene editing.

STAR PROTOCOLS (2021)

Article Biotechnology & Applied Microbiology

Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency

Cheng-Han Chung et al.

MOLECULAR THERAPY (2020)

Review Biochemistry & Molecular Biology

Gene editing and CRISPR in the clinic: current and future perspectives

Matthew P. Hirakawa et al.

BIOSCIENCE REPORTS (2020)

Article Biochemistry & Molecular Biology

Highly Parallel Profiling of Cas9 Variant Specificity

Jonathan L. Schmid-Burgk et al.

MOLECULAR CELL (2020)

Review Biochemistry & Molecular Biology

Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing

Giulia Maule et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biotechnology & Applied Microbiology

Prediction of the sequence-specific cleavage activity of Cas9 variants

Nahye Kim et al.

NATURE BIOTECHNOLOGY (2020)

Letter Biotechnology & Applied Microbiology

CRISPResso2 provides accurate and rapid genome editing sequence analysis

Kendell Clement et al.

NATURE BIOTECHNOLOGY (2019)

Article Biotechnology & Applied Microbiology

iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity

Christopher L. Nobles et al.

GENOME BIOLOGY (2019)

Article Pharmacology & Pharmacy

Delivering CRISPR: a review of the challenges and approaches

Christopher A. Lino et al.

DRUG DELIVERY (2018)

Article Biotechnology & Applied Microbiology

A highly specific SpCas9 variant is identified by in vivo screening in yeast

Antonio Casini et al.

NATURE BIOTECHNOLOGY (2018)

Article Multidisciplinary Sciences

Chromatin accessibility is associated with CRISPR-Cas9 efficiency in the zebrafish (Danio rerio)

Meri I. E. Uusi-Makela et al.

PLOS ONE (2018)

Article Multidisciplinary Sciences

Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo

Robert M. Yarrington et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

Directed evolution of CRISPR-Cas9 to increase its specificity

Jungjoon K. Lee et al.

NATURE COMMUNICATIONS (2018)

Editorial Material Multidisciplinary Sciences

Cas9 immunity creates challenges for CRISPR gene editing therapies

Julie M. Crudele et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells

Alewo Idoko-Akoh et al.

SCIENTIFIC REPORTS (2018)

Article Multidisciplinary Sciences

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy

Janice S. Chen et al.

NATURE (2017)

Article Multidisciplinary Sciences

Hit and go CAS9 delivered through a lentiviral based self-limiting circuit

Gianluca Petris et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Rationally engineered Cas9 nucleases with improved specificity

Ian M. Slaymaker et al.

SCIENCE (2016)

Article Multidisciplinary Sciences

CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells

Daniel P. Dever et al.

NATURE (2016)

Article Multidisciplinary Sciences

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects

Benjamin P. Kleinstiver et al.

NATURE (2016)

Article Biochemical Research Methods

A multifunctional AAV-CRISPR-Cas9 and its host response

Wei Leong Chew et al.

NATURE METHODS (2016)

Article Biotechnology & Applied Microbiology

Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection

Xiquan Liang et al.

JOURNAL OF BIOTECHNOLOGY (2015)

Article Biotechnology & Applied Microbiology

GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

Shengdar Q. Tsai et al.

NATURE BIOTECHNOLOGY (2015)

Article Biochemistry & Molecular Biology

Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA

Hiroshi Nishimasu et al.

Article Biochemistry & Molecular Biology

Easy quantitative assessment of genome editing by sequence trace decomposition

Eva K. Brinkman et al.

NUCLEIC ACIDS RESEARCH (2014)

Article Multidisciplinary Sciences

Multiplex Genome Engineering Using CRISPR/Cas Systems

Le Cong et al.

SCIENCE (2013)